Vocal Biomarkers Market - Business Top Impacting Factors is expected to grow from US$ 6.4 million by 2017 to US$ 1.6 Billion by 2028 at a CAGR of 65.7% between 2017 and 2028

The Global Vocal Biomarkers Market is estimated to be valued at US$ 6.4 million by 2017 and is projected to expand at an astounding CAGR of 65.7% from 2017 to 2028, as analyzed by Coherent Market Insights. Vocal biomarkers enabling early diagnosis and being a non-invasive procedure are analyzed to be major factor fueling uptake of this disruptive technology over the forecast period (2017–2028).

Sound vibrations are used as part of therapeutic healing for various mental health conditions such as depression and anxiety. Recent research studies, however, have greatly broadened its application into diagnosis of diseases. Biomarkers in the voice of a person have been linked to disorders such as depression, coronary artery disease, and anxiety. On successful completion of clinical trials, HIPAA compliant vocal biomarker system would serve as much more effective alternative to current diagnostic techniques such as MRI, X-Ray, and CT scan. Research is also underway for identifying vocal biomarkers in diagnosis of Parkinson’s disease, traumatic brain injury, cognitive impairment, and respiratory disorders, which would open up a highly lucrative avenue for growth for players in this industry. Companies dealing with voice technology are sampling data to provide accurate results. For instance, Beyond Verbal, Inc. has been researching on vocal biomarkers since 1996, and has collected over 2.5 million voice samples in over 40 different languages.

For In depth Information Get FREE Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/101

Key companies covered as a part of this study:
1. Beyond Verbal, Inc.
2. Cogito Corporation
3. Sonde Health
4. Sharecare, Inc.
5. IBM Corporation

Market Dynamics

Still in the clinical stage, the global vocal biomarkers technology would transform the way we mental and physical health is diagnosed and would transform the healthcare industry. This voice-based technology would allow for early diagnosis of diseases and accordingly help in taking preventive measures. This can significantly benefit military, hospitals and health clinics, and also individuals to monitor health and take appropriate medical action.

Collaborative efforts across different ecosystem players are bringing positive traction in global vocal biomarkers market. Sonde Health obtained technology license from the Massachusetts Institute of Technology Lincoln Laboratory for the latter’s voice-based technology platform intended for monitoring and diagnosis of various mental and physical conditions. Beyond Verbal, Inc. collaborated with Mayo Clinic in 2016 to conduct studies and identify the vocal biomarkers that could help in diagnosing mental and physical health.

Market Taxonomy

This report segments the vocal biomarkers market on the basis of application and end users. On the basis of application the vocal biomarkers market is segmented into psychological disorders, respiratory disorders and cardiovascular disorders. End users of this technology as covered in the report are hospitals, academic & research institutes, health insurers, and military. The market potential for vocal biomarkers has been analyzed across major geographies, namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Browse Press Release: https://www.coherentmarketinsights.com/press-release/vocal-biomarkers-market-to-reach-us-16-billion-by-2028-17

Key features of the study:

-This report provides in-depth analysis of the vocal biomarkers and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2017 – 2028),
-It elucidates potential revenue opportunity across different segments and details attractive investment proposition matrix for this market
-This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
-It profiles leading players in the global vocal biomarkers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
-Key companies covered as a part of this study include Beyond Verbal, Inc., Cogito Corporation, Sonde Health, Sharecare, Inc., and IBM Corporation
-Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology upgrade, market expansion and marketing tactics
-The global vocal biomarkers market report caters to various stakeholders in this industry including investors, device manufacturers, system manufacturers, distributors, new entrants, and financial analysts
-Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the vocal biomarkers market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com